A review of Indian research on co-occurring cannabis use disorders & psychiatric disorders

被引:0
作者
Singh, Shalini [1 ]
Balhara, Yatan Pal Singh [1 ,2 ]
机构
[1] All India Inst Med Sci, Dept Psychiat, New Delhi, India
[2] All India Inst Med Sci, Natl Drug Dependence Treatment Ctr, New Delhi, India
关键词
Cannabis; comorbidity; dual diagnosis; dual disorders; psychosis; schizophrenia; substance use disorders; SUBSTANCE USE DISORDERS; COGNITIVE FUNCTIONS; DUAL DIAGNOSIS; PSYCHOTIC REACTIONS; DRUG-ABUSE; SCHIZOPHRENIA; ADDICTION; PATTERNS; RISK; PSYCHOPATHOLOGY;
D O I
10.4103/ijmr.IJMR_791_15
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background & objectives: Cannabis is a widely used illicit drug and its use is often associated with co-occurring psychiatric disorders. This systematic review was aimed to provide information on the published Indian studies on co-occurring cannabis use disorders and psychiatric disorders. Methods: An electronic search of available Indian literature using relevant search terms was carried out in May 2015 and 52 articles in English language published from India were included in the current review. Results: Studies on cannabis and associated psychotic disorders (n=16) chiefly described acute episodes with predominant positive symptoms, following cannabis use. Some studies (n=6) observed an overall increased prevalence of all psychiatric disorders and symptoms owing to cannabis use, while others (n=14) elaborated on high rates of substance use in those with psychiatric disorders. The effect of cannabis use on cognitive function was the focus of some of the Indian studies (n=7). All these studies barring one had all male subjects, and a single study described the service delivery model for those with dual diagnosis disorders in India. Most of the research used cross-sectional observational design and focussed on treatment-seeking population. Interpretation & conclusions: A review of Indian literature on cannabis use and its association with psychiatric disorders indicates a high co-prevalence of psychotic disorders, especially in vulnerable individuals as well as high rates of co-occurrence of other psychiatric comorbidities. However, there is limited focus on exploring the aetiological association between cannabis use and psychiatric disorders; understanding the neurobiology of this association and management-related issues.
引用
收藏
页码:186 / 195
页数:10
相关论文
共 67 条
[1]   Substance-induced psychotic disorders: 13-Year data from a de-addiction centre and their clinical implications [J].
Aggarwal, Munish ;
Banerjee, Anindya ;
Singh, Shubh Mohan ;
Mattoo, S. K. ;
Basu, D. .
ASIAN JOURNAL OF PSYCHIATRY, 2012, 5 (03) :220-224
[2]  
Agrawal A.K., 1975, Indian Journal of Psychiatry, V17, P1
[3]  
Aich T, 2005, INDIAN J PSYCHIAT, V47, P33
[4]  
Aich Tapas K, 2004, Indian J Psychiatry, V46, P135
[5]   Cannabis use, schizotypy, and negative priming [J].
Albertella, Lucy ;
Le Pelley, Mike E. ;
Copeland, Jan .
PSYCHIATRY RESEARCH, 2015, 228 (03) :404-410
[6]  
[Anonymous], 2014, WORLD DRUG REP 2014
[7]  
Bagadia V, 1976, INDIAN J PSYCHIAT, V18, P141
[8]  
Bannerjee S., 1997, Journal of the Indian Academy of Applied Psychology, V23, P13
[9]  
Basu D, 1994, Indian J Psychiatry, V36, P121
[10]  
Basu D, 2000, Indian J Psychiatry, V42, P34